Brief: Olema Oncology Announces Departure Of Chief Operating And Financial Officer
30/01/2026 21:05
Olema Pharmaceuticals Inc OLMA.O: OLEMA ONCOLOGY ANNOUNCES DEPARTURE OF CHIEF OPERATING AND FINANCIAL OFFICER OLEMA PHARMACEUTICALS INC - ONCOLOGY ANNOUNCES DEPARTURE OF COO AND CFO SHANE KOVACS OLEMA PHARMACEUTICALS INC - BEGINS SEARCH FOR NEW CFO; APPOINTS SEAN P. BOHEN AS INTERIM CFO Source text: ID:nGNX77Z18P Further company coverage: OLMA.O
Recent news on Olema Pharmaceuticals
See all newsOlema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Olema Pharmaceuticals Q2 net loss widens on higher clinical trial spending
Brief: Olema Pharmaceuticals Q2 Net Income USD -63.2 Million
Brief: Olema Oncology Announces Clinical Trial Collaboration And Supply Agreement With Bayer To Evaluate Op-3136 In Combination With Nubeqa® (Darolutamide) In Metastatic Castration-Resistant Prostate Cancer
Olema Pharmaceuticals Q1 net loss widens on higher R&D costs